University of Pennsylvania, Penn Memory Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Arnold, Steven E
LIFT-AD, NCT04488419: ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Completed
2/3
554
US
ATH-1017, Placebo
Athira Pharma
Alzheimer Disease, Dementia of Alzheimer Type
07/24
07/24
NCT05004688: A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Active, not recruiting
2
15
US
Biological/Vaccine: Bacillus Calmette-Guerin (BCG), BCG
Steven E Arnold, MD
Mild Cognitive Impairment, Mild Dementia, Moderate Dementia, Alzheimer Disease
10/23
10/23
NADALS, NCT05189106: Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis () Basket Trial

Active, not recruiting
1/2
20
US
Baricitinib, Olumiant, INCB28050, LY3009104
Massachusetts General Hospital
Amyotrophic Lateral Sclerosis, Alzheimer Disease, Mild Cognitive Impairment
12/24
06/25
NCT06297590: A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Recruiting
1
32
Europe, Japan, US
LY3954068, Placebo, Flortaucipir F18
Eli Lilly and Company
Alzheimer Disease
02/27
02/27
NCT04606420: Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease

Active, not recruiting
N/A
51
US
Lifestyle medicine
Preventive Medicine Research Institute, University of California, San Francisco, Harvard Medical School (HMS and HSDM), University of California, San Diego, The Cleveland Clinic, Renown Health
Alzheimer Disease
09/23
09/23
NCT05124392: Biomarker Profiling in Individuals at Risk for Prion Disease

Recruiting
N/A
80
US
Massachusetts General Hospital, Broad Institute
CJD (Creutzfeldt Jakob Disease), Prion Diseases, GSS, FFI, Familial Fatal Insomnia
06/25
06/25

Download Options